Together we will beat cancer

Donate

Cancer Research UK launches trial to test new drug in patients with advanced cancer

A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK today.

Read More

New bladder cancer therapy to start clinical trials

An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.

Read More

Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer.

Read More

Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies

Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic.

Read More

Cancer Research Technology pioneer fund announces investment in blood cancer drugs

The Cancer Research Technology (CRT) Pioneer Fund announced an investment to develop a promising new class of drugs for blood cancer.

Read More

CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration

Cancer Research Technology (CRT) has today received a success payment from GlaxoSmithKline resulting from its research collaboration.

Read More

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

Read More

Scientists discover drug combination slows lung cancer cell growth

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.

Read More

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

Read More

Cancer Research Technology Pioneer Fund boosts investment in drugs that block cancer defences

The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs.

Read More